Boost Data Transparency with APCDs

All-payer claims databases (APCDs) would benefit from mapping morbidity rates to the data resulting in pricing transparency, as well as pricing, efficiency and performance assessments that can be compared among providers. Mapping morbidity rates using publicly available data would create a clear idea of healthcare effectiveness and enrich the data, enabling patterns of care and value to emerge and in result, improve the future of healthcare. Here's a preview of Virginia Long and David Mould's piece on iHealthBeat that went live today:

All-payer claims databases (APCDs) that are in place in several states and about to be implemented in many more, are intended to make provider and hospital costs transparent.  The readily available data within the APCDs includes claims data for medical, mental health, pharmacy, and dental procedures across providers.  Access to this data enables analysis, analysis that can be done to make important comparisons such as price for services or performance measures at the level of physician or hospital—across a state.  Thus, the APCDs can provide powerful and illuminating information, from tracking state healthcare spending to guiding patient/consumer choices.

Augmenting APCD data

Although APCDs can provide useful information on cost and value of healthcare within a state, augmenting the claims data with publically available morbidity data would provide users with a more holistic dataset where cost information is directly tied to clinical outcomes.  Mapping disease morbidity information to APCDs would allow effectiveness of treatment to be assessed, alongside cost and quality measures.  Treatment costs relative to disease burden within distinct locations can be used to pinpoint areas with health disparities, highlighting potential problems or incongruities in access to or quality of care. 

Health and Morbidity Data

Publically available health data is available through many sources.  A few of the major health related data sources are the Center for Disease Control and Prevention (CDC), the Community Health Status Indicators (CHSI), and the County Health Rankings.  The CDC is not just concerned with communicable diseases; they are at the forefront of the fight against chronic diseases that adversely affect health in America.  CDC data on disease are readily available and data maps for social determinants of health have the potential to bring together highly relevant and sometimes overlooked data. The CHSI provides information on health indicators such as tobacco use, diet and activity, alcohol and drug use, to create community profiles.  Measures of health, causes of death, population vulnerability, and access to care, demographics, and risk factors are among the reports available on a county by county basis.  The County Health Rankings & Roadmap program collects data about factors that influence health that includes high school graduation rates, obesity, unemployment, access to healthful foods, air and water quality. County Health Rankings provides information about health outcomes such as length of life and quality of life, as measured by poor health, poor mental health, and low birth weight.

Integration of public datasets with the APCDs

The addition of health factors and morbidity data would create a rich data set. Advanced analysis of the APCDs in conjunction with health and morbidity measurements will highlight interesting, important, or overlooked relationships among claims data, health outcomes, and factors influencing health.  Through exploring and understanding these relationships, all stakeholders in the healthcare system will have a better understanding of how cost, quality, and effectiveness of care intersect.  Literal mapping of these data, by using location based datasets, would enable users of all analytic levels to consume the data visually.

To read more about Virginia Long and David Mould’s thoughts on APCDs, visit the full iHealthBeat post, “Link All-Payer Claims Databases With Other Data To Boost Transparency.”

Posted in

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

Data visualization: A picture is worth a thousand…healthcare data points?

Data visualization: A picture is worth a thousand…healthcare data points?

January 12, 2021

The amount of data produced daily has grown exponentially with nearly 90% of the world’s data generated in the last two years alone. To ensure we can make sense of this data, analysts must find meaningful ways to present the information to their audiences.

Read on...

How did we get here? Hospital analytics and the new normal

July 15, 2020

I have heard the word “unprecedented” so many times in 2020 that it has lost its significance; many of us have become desensitized to the extraordinary changes in the world this year.

Read on...

How to help employer groups plan in a time of uncertainty

June 15, 2020

Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”

Read on...

Healthcare’s return to “normal” after COVID-19: Is it possible?

June 9, 2020

As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”

Read on...